Abstract: Provided is a method of processing elastic wave data, the method including selecting some elastic wave traces as a first label from among a plurality of elastic wave traces received without at least some elastic wave traces missing from whole elastic wave data, training an interpolation model on a machine learning basis by using at least two or more of remaining elastic wave traces except for the first label and the first label, restoring the at least some elastic wave traces missing from the whole elastic wave data by using the trained interpolation model, training an extrapolation model on a machine learning basis by using an elastic wave trace selected as a second label from among a plurality of elastic wave traces included in whole restored elastic wave data and at least two or more of remaining elastic wave traces except for the second label, and generating an additional elastic wave trace, which have not been included in the whole elastic wave data, by using the trained extrapolation model.

Abstract: An interconnection structure for a semiconductor device may include lower interconnection patterns disposed in a checker board shape and upper interconnection patterns disposed in a checker board shape and connecting two adjacent lower interconnection patterns to each other.

Abstract: An interconnection structure for a semiconductor device may include lower interconnection patterns disposed in a checker board shape and upper interconnection patterns disposed in a checker board shape and connecting two adjacent lower interconnection patterns to each other.

Abstract: The present invention relates to 4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them. More particularly, it relates to 4-hydroxycinnamamide derivatives showing superior antioxidant activity compared to the known antioxidant compounds, their pharmaceutically acceptable salt, and pharmaceutical compositions containing them. It can be usefully used in treating neurodegerative diseases such as aging, cancer, diabetes, ischemic stroke, Parkin's disease, dementia and Huntinton's disease.

Abstract: The present invention relates to 4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them. More particularly, it relates to 4-hydroxycinnamamide derivatives showing superior antioxidant activity compared to the known antioxidant compounds, their pharmaceutically acceptable salt, and pharmaceutical compositions containing them. It can be usefully used in treating neurodegerative diseases such as aging, cancer, diabetes, ischemic stroke, Parkin's disease, dementia and Huntinton's disease.